{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:27:29Z","timestamp":1740108449683,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00296-019-04471-w","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T08:03:26Z","timestamp":1573113806000},"page":"785-789","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Glomerulonephritis and Coombs-positive hemolytic anemia mimicking scleroderma renal crisis in an overlap of systemic lupus erythematosus and diffuse systemic sclerosis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5758-1825","authenticated-orcid":false,"given":"Ali","family":"Taylan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7297-9869","authenticated-orcid":false,"given":"Emel","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5755-0132","authenticated-orcid":false,"given":"Bahar","family":"Engin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,7]]},"reference":[{"issue":"11","key":"4471_CR1","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1136\/ard.49.11.947","volume":"49","author":"R Cervera","year":"1990","unstructured":"Cervera R, Khamashta MA, Hughes GR (1990) 'Overlap' syndromes. Ann Rheum Dis 49(11):947\u2013948. \nhttps:\/\/doi.org\/10.1136\/ard.49.11.947","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"4471_CR2","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3899\/jrheum.170953","volume":"45","author":"S Alharbi","year":"2018","unstructured":"Alharbi S, Ahmad Z, Bookman AA, Touma Z, Sanchez-Guerrero J et al (2018) Epidemiology and survival of systemic sclerosis-systemic lupus erythematosus overlap syndrome. J Rheumatol. 45(10):1406\u20131410. \nhttps:\/\/doi.org\/10.3899\/jrheum.170953\n\n(Epub 2018 Jul 15)","journal-title":"J Rheumatol."},{"issue":"11","key":"4471_CR3","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.3899\/jrheum.101248","volume":"38","author":"A Pakozdi","year":"2011","unstructured":"Pakozdi A, Nihtyanova S, Moinzadeh P, Ong VH, Black CM et al (2011) Clinical and serological hallmarks of systemic sclerosis overlap syndromes. J Rheumatol 38(11):2406\u20132409. \nhttps:\/\/doi.org\/10.3899\/jrheum.101248\n\n(Epub 2011 Aug 15)","journal-title":"J Rheumatol"},{"issue":"4","key":"4471_CR4","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/annrheumdis-2013-204487","volume":"74","author":"P Moinzadeh","year":"2015","unstructured":"Moinzadeh P, Aberer E, Ahmadi-Simab K, Blank N, Distler JH et al (2015) Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 74(4):730\u2013737. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2013-204487\n\n(Epub 2014 Jan 3)","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4471_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","volume":"52","author":"GC Sharp","year":"1972","unstructured":"Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR (1972) Mixed connective tissue disease\u2013an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 52(2):148\u2013159","journal-title":"Am J Med."},{"issue":"11","key":"4471_CR6","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 72(11):1747\u20131755. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis."},{"issue":"8","key":"4471_CR7","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, Gordon C, Merrill JT et al (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 64(8):2677\u20132686. \nhttps:\/\/doi.org\/10.1002\/art.34473","journal-title":"Arthritis Rheum."},{"issue":"5\u20136","key":"4471_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1046\/j.1445-5994.2003.00358.x","volume":"33","author":"JG Walker","year":"2003","unstructured":"Walker JG, Ahern MJ, Smith MD, Coleman M, Pile K et al (2003) Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment. Intern Med J 33(5\u20136):216\u2013220","journal-title":"Intern Med J"},{"issue":"Suppl 3","key":"4471_CR9","doi-asserted-by":"publisher","first-page":"iii32","DOI":"10.1093\/rheumatology\/ken483","volume":"48","author":"CP Denton","year":"2009","unstructured":"Denton CP, Lapadula G, Mouthon L, M\u00fcller-Ladner U (2009) Renal complications and scleroderma renal crisis. Rheumatology (Oxford) 48(Suppl 3):iii32\u2013iii35. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/ken483","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"4471_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/BOR.0000000000000221","volume":"27","author":"M Hudson","year":"2015","unstructured":"Hudson M (2015) Scleroderma renal crisis. Curr Opin Rheumatol 27(6):549\u2013554. \nhttps:\/\/doi.org\/10.1097\/BOR.0000000000000221","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"4471_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2169\/internalmedicine.1441-18","volume":"58","author":"T Shimizu","year":"2019","unstructured":"Shimizu T, Iwamoto N, Okamoto M, Endo Y, Tsuji S et al (2019) Scleroderma renal crisis complicated with thrombotic microangiopathy triggered by influenza B virus infection. Intern Med. 58(3):441\u2013445. \nhttps:\/\/doi.org\/10.2169\/internalmedicine.1441-18\n\n(Epub 2018 Aug 24)","journal-title":"Intern Med."},{"issue":"2","key":"4471_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12016-009-8191-5","volume":"40","author":"L Mouthon","year":"2011","unstructured":"Mouthon L, B\u00e9rezn\u00e9 A, Bussone G, No\u00ebl LH, Villiger PM et al (2011) Scleroderma renal crisis: a rare but severe complication of systemic sclerosis. Clin Rev Allergy Immunol 40(2):84\u201391. \nhttps:\/\/doi.org\/10.1007\/s12016-009-8191-5","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"4471_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00296-010-1697-6","volume":"32","author":"G Trang","year":"2012","unstructured":"Trang G, Steele R, Baron M, Hudson M (2012) Corticosteroids and the risk of scleroderma renal crisis: a systematic review. Rheumatol Int 32(3):645\u2013653. \nhttps:\/\/doi.org\/10.1007\/s00296-010-1697-6\n\n(Epub 2010 Dec 4)","journal-title":"Rheumatol Int"},{"issue":"5","key":"4471_CR14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10067-014-2527-0","volume":"33","author":"E Pokroy-Shapira","year":"2014","unstructured":"Pokroy-Shapira E, Gelernter I, Molad Y (2014) Evolution of chronic kidney disease in patients with systemic lupus erythematosus over a long-period follow-up: a single-center inception cohort study. Clin Rheumatol. 33(5):649\u2013657. \nhttps:\/\/doi.org\/10.1007\/s10067-014-2527-0\n\n(Epub 2014 Feb 19)","journal-title":"Clin Rheumatol."},{"issue":"8","key":"4471_CR15","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.autrev.2017.05.017","volume":"16","author":"G Ruiz-Irastorza","year":"2017","unstructured":"Ruiz-Irastorza G, Ugarte A, Saint-Pastou Terrier C, Lazaro E, Iza A et al (2017) Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: an observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts. Autoimmun Rev. 16(8):826\u2013832. \nhttps:\/\/doi.org\/10.1016\/j.autrev.2017.05.017\n\n(Epub 2017 May 28)","journal-title":"Autoimmun Rev."},{"issue":"12","key":"4471_CR16","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1093\/rheumatology\/kep290","volume":"48","author":"T Satoh","year":"2009","unstructured":"Satoh T, Ishikawa O, Ihn H, Endo H, Kawaguchi Y et al (2009) Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay. Rheumatology (Oxford) 48(12):1570\u20131574. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/kep290\n\n(Epub 2009 Oct 5)","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"4471_CR17","first-page":"153","volume":"5","author":"A Alayoud","year":"2012","unstructured":"Alayoud A, Qamouss O, Hamzi MA, Benyahia M, Oualim Z (2012) Scleroderma renal crisis precipitated by steroid treatment in systemic lupus erythematosus and scleroderma overlap syndrome. Arab J Nephrol Transpl 5(3):153\u2013157","journal-title":"Arab J Nephrol Transpl"},{"issue":"3","key":"4471_CR18","doi-asserted-by":"publisher","first-page":"602","DOI":"10.4103\/1319-2442.182439","volume":"27","author":"R Tewari","year":"2016","unstructured":"Tewari R, Badwal S, Kumar A, Subramaniam S, Nijhawan SV, Srinivas V (2016) Anti-neutrophil cytoplasmic antibody negative crescentic paucimmune glomerulonephritis in a case of scleroderma with systemic lupus erythematosus overlap. Saudi J Kidney Dis Transpl. 27(3):602\u2013605","journal-title":"Saudi J Kidney Dis Transpl."},{"issue":"10","key":"4471_CR19","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1177\/0961203318785776","volume":"27","author":"E McConville","year":"2018","unstructured":"McConville E, Smith D, B\u00e9langer E, Ivory C (2018) Development of lupus nephritis in a patient with previous scleroderma renal crisis. Lupus. 27(10):1732\u20131734. \nhttps:\/\/doi.org\/10.1177\/0961203318785776\n\n(Epub 2018 Jul 20)","journal-title":"Lupus."},{"issue":"4","key":"4471_CR20","first-page":"142","volume":"113","author":"P Fraticelli","year":"2018","unstructured":"Fraticelli P, Fischetti C, Salaffi F, Carotti M, Mattioli M et al (2018) Combination therapy with rituximab and mycophenolate mofetil in systemic sclerosis. A single-centre case series study. Clin Exp Rheumatol 113(4):142\u2013145 (Epub 2018 Sep 30)","journal-title":"Clin Exp Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04471-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04471-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04471-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:19:11Z","timestamp":1604621951000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04471-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,7]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["4471"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04471-w","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"type":"print","value":"0172-8172"},{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2019,11,7]]},"assertion":[{"value":"21 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the individual participant included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}